Position in GEHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,130,045
New position
Shares Held
95,767
first reported quarter
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#215
of 1,218 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 51%
Shared 0%
None 49%
Position in Medical Devices
Healthcare · as of Jun 30, 2026Nykredit A/S holds $159,842,741 across 31 Medical Devices names. GEHC ranks #6 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
589,236 | $53,467,274 | |
| 2 | SYK |
Stryker Corp
|
107,310 | $33,785,480 | |
| 3 | BSX |
Boston Scientific Corp
|
582,416 | $24,857,514 | |
| 4 | EW |
Edwards Lifesciences Corp
|
228,193 | $20,642,338 | |
| 5 | DXCM |
Dexcom Inc
|
141,032 | $9,498,505 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
This page
|
95,767 | $6,130,045 | |
| 7 | PODD |
Insulet Corp
|
35,795 | $5,449,788 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
39,716 | $3,419,150 |
All Filings in GEHC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,130,045 | 95,767 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||